The cost impact of unselective vs selective MammaPrint testing in early-stage breast cancer in Southern Africa

BACKGROUND: MammaPrint (MP) has been applied in South Africa (SA) for decision-making in early-stage hormone receptor-positive breast cancer since 2006. The cost-impact of MP in SA has not been assessed. AIM: To assess different MP testing strategies for cost-minimization in early-stage breast carci...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Breast
Главные авторы: Myburgh, Ettienne J., de Jager, Josephus J., Murray, Elizabeth, Grant, Kathleen A., Kotze, Maritha J., de Klerk, Hermanus
Формат: Artigo
Язык:Inglês
Опубликовано: Elsevier 2021
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8259301/
https://ncbi.nlm.nih.gov/pubmed/34217105
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.breast.2021.05.010
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы